Page last updated: 2024-08-24

triazoles and er-086526

triazoles has been researched along with er-086526 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Akcakanat, A; Arango, NP; Evans, KW; Gonzalez-Angulo, AM; Janku, F; Kim, C; Meric-Bernstam, F; Naing, A; Scott, S; Tripathy, D; Ueno, NT; Yuca, E; Zhao, M	1

Other Studies

1 other study(ies) available for triazoles and er-086526

Article	Year
Selinexor (KPT-330) demonstrates anti-tumor efficacy in preclinical models of triple-negative breast cancer. Breast cancer research : BCR, 2017, Aug-15, Volume: 19, Issue:1 Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Proliferation; Doxorubicin; Female; Furans; Humans; Hydrazines; Ketones; MCF-7 Cells; Mice; Triazoles; Triple Negative Breast Neoplasms; Xenograft Model Antitumor Assays	2017

Article

Year

Selinexor (KPT-330) demonstrates anti-tumor efficacy in preclinical models of triple-negative breast cancer.

Breast cancer research : BCR, 2017, Aug-15, Volume: 19, Issue:1

Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Proliferation; Doxorubicin; Female; Furans; Humans; Hydrazines; Ketones; MCF-7 Cells; Mice; Triazoles; Triple Negative Breast Neoplasms; Xenograft Model Antitumor Assays

2017